Johnson & Johnson to Pay New York $230 Million to Settle Opioid Case – The New York Times

Johnson & Johnson, the parent company of Janssen Pharmaceutical Companies, which was set to be one of the defendants in the New York trial, will also pay an additional $33 million as reimbursement for New Yorks attorney fees and costs. The company will…

Click here to view the original article.